Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

JAK inhibitors show promise for treating various skin diseases.

Women with PCOS have a higher risk of heart disease.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New therapies are being developed that target integrin pathways to treat various diseases.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

COVID-19 affects multiple body systems, not just the lungs.

White oyster mushroom extracts may help dissolve blood clots.

A dog with a rare heart clot died despite treatment, highlighting the need for better clot treatments in dogs.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Thyroid dysfunction can cause heart issues, and bedside ultrasound helps diagnose cardiac arrest causes.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.